Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPHI-DACI: Lidocaine Block for Chronic Ano-Perineal Pain
NCT06602349Recruiting
- Sponsor
- Groupe Hospitalier Diaconesses Croix Saint-Simon
- Start
- Dec 2023
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Anorectal pain comparing Lidocaine Arm with Placebo Arm (2 arms). Primary endpoint: Rate of patients with a reduction of at least 3 points on VAS at 1 month. Started Dec 2023; status: recruiting.
02
Drugs
lidocaine
03
Conditions
Anorectal pain
Beyond the preview
Go deeper on NCT06602349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06602349.